SEC filing · 8-K

Carlsmed, Inc.: Executive or director change

Carlsmed appointed Richard Heppenstall as Chief Financial Officer to succeed Leo Greenstein and reaffirmed its full year 2026 revenue guidance.

Filed September 30, 2026

Neutral news

What happened

Leo Greenstein departed as Chief Financial Officer effective September 25, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Carlsmed, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.